Banco de Sabadell’s Encompass Health EHC Stock Holding History

Banco de Sabadell’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24,895	Closed	-$978K	–	408
2017 Q4	$978K	Buy	+24,895	New	+$947K	0.13%	163

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Banco de Sabadell's EHC Position: Q1 2018 in Review

Banco de Sabadell sold out of Encompass Health (EHC) in Q1 2018, closing a stake of 24,895 shares — an estimated $978K sold.

Banco de Sabadell first reported a position in EHC in Q4 2017 and held it in 1 quarter. The position peaked at $978K in Q4 2017. 354 funds tracked by Wall St. Rank hold EHC as of Q1 2018.

Banco de Sabadell reported no remaining Encompass Health position as of Q1 2018 after selling out during the quarter.
Banco de Sabadell sold 24,895 Encompass Health shares in Q1 2018, an estimated $978K.
Banco de Sabadell first reported a position in Encompass Health in Q4 2017 and held it in 1 quarter.
Banco de Sabadell's Encompass Health position peaked at $978K in Q4 2017.
354 funds tracked by Wall St. Rank held Encompass Health as of Q1 2018.

Based on Banco de Sabadell's 13F filing for Q1 2018, filed 16 May 2018.